Alyeska Investment Group
TRIV

Alyeska Investment Group’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

Alyeska Investment Group’s Portfolio TRIV Stock Details TRIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-19,267
Closed -$96K – 547
2015
Q3 		$96K Buy
+19,267
New +$103K ﹤0.01% 455

Other funds holding TRIV

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alyeska Investment Group's TRIV Position: Q4 2015 in Review

Alyeska Investment Group sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q4 2015, closing a stake of 19,267 shares — an estimated $96K sold.

Alyeska Investment Group first reported a position in TRIV in Q3 2015 and held it in 1 quarter. The position peaked at $96K in Q3 2015. 25 funds tracked by Wall St. Rank hold TRIV as of Q4 2015.

  • Alyeska Investment Group reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q4 2015 after selling out during the quarter.
  • Alyeska Investment Group sold 19,267 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q4 2015, an estimated $96K.
  • Alyeska Investment Group first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q3 2015 and held it in 1 quarter.
  • Alyeska Investment Group's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $96K in Q3 2015.
  • 25 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q4 2015.

Based on Alyeska Investment Group's 13F filing for Q4 2015, filed 16 Feb 2016.